• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Codes Activation, Positioning or Separation Problem (2906); Material Integrity Problem (2978); Migration (4003)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/10/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the stent partially deployed and was potentially stretched as a result.Additionally, the stent migrated post-deployment.An eluvia drug-eluting vascular stent system was selected for use in the superficial femoral artery (sfa) to treat the patient's peripheral artery disease.The eluvia was advanced to the target lesion over an unknown 0.014 in.Guidewire via a contralateral approach and deployment began.Once the stent was deployed approximately half-way, the thumbwheel became loose, and was just spinning, not allowing the stent to fully deploy.The delivery system handle was dismantled, and deployment was completed using a pin-pull method with the innermost catheter and the middle catheter.This allowed the stent to be deployed with integrity.However, the stent appeared to have migrated proximally and may have covered the origin of the profunda.The stent may have been stretched or elongated as a result of the partial deployment.The procedure was completed, and there were no further consequences reported for the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16679163
Report Number2124215-2023-15744
Device Sequence Number18162598
Product Code NIU
UDI-Device Identifier08714729876731
UDI-Public08714729876731
Combination Product (Y/N)Y
Initial Reporter StateSD
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/03/2024
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0028889918
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/10/2023
Initial Report FDA Received Date04/04/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/03/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-